Senti Biosciences Holdings Operating Margin Growth & History (SNTI)
Senti Biosciences Holdings's operating margin was −312,631.82% for fiscal 2025.
View full Senti Biosciences Holdings company overviewSenti Biosciences Holdings annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −312,631.82% | — |
| 2023 | 2023-12-31 | −4,687.92% | −2798.57 pp |
| 2022 | 2022-12-31 | −1,889.35% | −123.92 pp |
| 2021 | 2021-12-31 | −1,765.43% | — |
Senti Biosciences Holdings quarterly operating margin
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −85,229.41% | — |
| Q1 2026 | 2026-03-31 | −28,850.00% | — |
| Q4 2025 | 2025-12-31 | −84,709.09% | — |
| Q3 2023 | 2023-09-30 | −17,206.27% | −16233.45 pp |
| Q2 2023 | 2023-06-30 | −2,210.77% | −245.88 pp |
| Q1 2023 | 2023-03-31 | −1,444.40% | −67.59 pp |
| Q3 2022 | 2022-09-30 | −972.82% | +260.76 pp |
| Q2 2022 | 2022-06-30 | −1,964.89% | −808.59 pp |
| Q1 2022 | 2022-03-31 | −1,376.81% | — |
| Q3 2021 | 2021-09-30 | −1,233.59% | — |
| Q2 2021 | 2021-06-30 | −1,156.30% | — |
Senti Biosciences Holdings operating margin trends
Between the periods ended 2021-12-31 and 2025-12-31, Senti Biosciences Holdings's operating margin decreased from −1,765.43% to −312,631.82%, a change of −310866.39 percentage points. The latest reported quarter, Q2 2026, shows −85,229.41%.
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Senti Biosciences Holdings source filings ↗